{"transactions":[{"id":860981,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:48:18.000Z","date":"2026-03-02","kind":"grant","planned":false,"acquired":true,"shares":26921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Holdings include unvested restricted stock units (\"RSUs\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on June 11, 2026."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Holdings include unvested restricted stock units (\"RSUs\")."}],"balance_after":101926,"source":{"system":"sec-edgar","filing":"0001193125-26-092253","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000119312526092253/ownership.xml","form_type":"4"}},{"id":932058,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-23T19:42:44.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units (\"RSUs\") that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2027."}],"balance_after":75005,"source":{"system":"sec-edgar","filing":"0001193125-26-021411","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000119312526021411/ownership.xml","form_type":"4"}},{"id":1622120,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-02-23T17:00:32.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2024 pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option award becomes exercisable in three equal annual installments beginning January 2, 2025."}],"balance_after":600,"derivative":{"exercise_price":1.59,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001209191-24-003902","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919124003902/doc4.xml","form_type":"4"}},{"id":2038339,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-02-01T20:30:36.000Z","date":"2023-01-30","kind":"grant","acquired":true,"shares":9621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning January 30, 2024."}],"balance_after":9621,"derivative":{"exercise_price":4.02,"expiration_date":"2033-01-30","underlying":"Common Stock","underlying_shares":9621},"source":{"system":"sec-edgar","filing":"0001209191-23-006051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919123006051/doc4.xml","form_type":"4"}},{"id":2103225,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-28T17:00:17.000Z","date":"2022-11-23","kind":"purchase","acquired":true,"shares":10000,"price":0.17,"value":1700.0,"ownership":{"direct":true},"balance_after":162857,"source":{"system":"sec-edgar","filing":"0001209191-22-058875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919122058875/doc4.xml","form_type":"4"}},{"id":2174742,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-08-24T08:55:31.000Z","date":"2022-08-22","kind":"purchase","acquired":true,"shares":20000,"price":0.26,"value":5200.0,"ownership":{"direct":true},"balance_after":152857,"source":{"system":"sec-edgar","filing":"0001209191-22-047297","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919122047297/doc4.xml","form_type":"4"}},{"id":2267560,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-17T16:14:45.000Z","date":"2022-05-16","kind":"purchase","acquired":true,"shares":100000,"price":0.1963,"value":19630.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.1911 to $0.1963, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc., any security holder of ENDRA Life Sciences Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote."}],"balance_after":132857,"source":{"system":"sec-edgar","filing":"0001209191-22-029593","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919122029593/doc4.xml","form_type":"4"}},{"id":2314059,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-03-30T17:15:41.000Z","date":"2022-03-28","kind":"grant","acquired":true,"shares":109323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning March 28, 2023."}],"balance_after":109323,"derivative":{"exercise_price":0.38,"expiration_date":"2032-03-28","underlying":"Common Stock","underlying_shares":109323},"source":{"system":"sec-edgar","filing":"0001209191-22-021623","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919122021623/doc4.xml","form_type":"4"}},{"id":2447910,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2022-01-04T17:07:49.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 3, 2022 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":0.74,"exercise_date":"2023-01-03","expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-22-000961","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919122000961/doc4.xml","form_type":"4"}},{"id":2754030,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-04-07T16:18:02.000Z","date":"2021-04-05","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022."}],"balance_after":25000,"derivative":{"exercise_price":2.64,"expiration_date":"2031-04-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-025866","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919121025866/doc4.xml","form_type":"4"}},{"id":2771734,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2021-03-25T17:00:50.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 4, 2021 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":0.8,"exercise_date":"2022-01-04","expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-21-023039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919121023039/doc4.xml","form_type":"4"}},{"id":2912016,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-08T19:10:55.000Z","date":"2021-01-08","kind":"sale","acquired":false,"shares":10000,"price":0.9,"value":9000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan in order to pay the tax liability associated with the vesting of restricted stock units which were granted to the Reporting Person on April 9, 2020."}],"balance_after":32857,"source":{"system":"sec-edgar","filing":"0001209191-21-002827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919121002827/doc4.xml","form_type":"4"}},{"id":3177817,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-13T16:46:56.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":42857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted in lieu of the Reporting Person's cash retainer payable under the Issuer's Non-Employee Director\nCompensation Policy for the second, third and fourth quarters of 2020. The restricted stock units vest in three equal installments on the last day\nof each such calendar quarter. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."}],"balance_after":42857,"source":{"system":"sec-edgar","filing":"0001209191-20-024217","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919120024217/doc4.xml","form_type":"4"}},{"id":3317738,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2020-01-06T16:23:45.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2020 pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":12000,"derivative":{"exercise_price":1.9,"exercise_date":"2021-01-02","expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-20-001805","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919120001805/doc4.xml","form_type":"4"}},{"id":3344967,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2019-12-11T17:53:18.000Z","date":"2019-12-11","kind":"grant","acquired":true,"shares":89585,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest and become exercisable in three equal annual installments beginning on the one year anniversary of the grant date."}],"balance_after":89585,"derivative":{"exercise_price":0.9,"expiration_date":"2029-12-11","underlying":"Common Stock","underlying_shares":89585},"source":{"system":"sec-edgar","filing":"0001209191-19-060092","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919119060092/doc4.xml","form_type":"4"}},{"id":3576285,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2019-03-27T20:01:56.000Z","date":"2019-03-25","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on March 25, 2019 pursuant to the Issuer's Non-Employee Director Compensation Policy."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This stock option grant becomes exercisable in three equal annual installments beginning March 25, 2020."}],"balance_after":50000,"derivative":{"exercise_price":3.09,"expiration_date":"2019-03-25","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-19-021506","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919119021506/doc4.xml","form_type":"4"}},{"id":4106940,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true}}],"security":"Stock Options","published_at":"2018-01-04T19:43:57.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":6061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a stock option award granted on January 2, 2018 pursuant to the Issuer's Non-Employee\nDirector Compensation Policy."}],"balance_after":6061,"derivative":{"exercise_price":4.95,"exercise_date":"2019-01-02","expiration_date":"2026-01-02","underlying":"Common Stock","underlying_shares":6061},"source":{"system":"sec-edgar","filing":"0001654954-18-000114","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000165495418000114/section16.xml","form_type":"4"}},{"id":4307814,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-05-23T18:05:04.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This amendment is being filed to correct the exercisable date of these Stock Options, which was inadvertantly reported as May 12, 2017. The correct exercisable date is December 31, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The\ncorrect expiration date is May 12, 2025."}],"balance_after":6000,"derivative":{"exercise_price":5,"exercise_date":"2017-12-31","expiration_date":"2025-05-12","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-034737","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919117034737/doc4a.xml","form_type":"4/A","original_submission_date":"2017-05-18"}},{"id":4307813,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-05-23T18:05:04.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This amendment is being filed to correct the expiration date of these Stock Options, which was inadvertantly reported as May 12, 2022. The\ncorrect expiration date is May 12, 2025."}],"balance_after":6000,"derivative":{"exercise_price":5,"exercise_date":"2017-05-12","expiration_date":"2025-05-12","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-17-034737","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919117034737/doc4a.xml","form_type":"4/A","original_submission_date":"2017-05-18"}},{"id":4313338,"issuer":{"id":8083,"kind":"organization","name":"ENDRA Life Sciences Inc."},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-05-18T16:25:52.000Z","date":"2017-05-12","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12000,"derivative":{"exercise_price":5,"exercise_date":"2017-05-12","expiration_date":"2022-05-12","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-17-033586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1334483/000120919117033586/doc4.xml","form_type":"4"}},{"id":4460956,"issuer":{"id":1053,"kind":"organization","name":"MICROVISION, INC.","symbol":"MVIS"},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Option (right to buy)","published_at":"2017-02-09T22:15:49.000Z","date":"2017-02-08","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reporting person vests ownership in this stock option as follows:  25% upon each annual anniversary of the date of grant, subject to the terms of the 2013 Stock Option Plan, as amended."}],"balance_after":150000,"derivative":{"exercise_price":1.67,"exercise_date":"2018-02-08","expiration_date":"2027-02-08","underlying":"MicroVision Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001593968-17-000247","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/65770/000159396817000247/primary_01.xml","form_type":"4"}},{"id":4523097,"issuer":{"id":1053,"kind":"organization","name":"MICROVISION, INC.","symbol":"MVIS"},"owners":[{"id":62784,"kind":"person","name":"Tokman Alexander Y","position":1,"cik":"0001334483","reported_name":"Tokman Alexander Y","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2016-12-14T21:39:15.000Z","date":"2016-12-14","kind":"purchase","acquired":true,"shares":46730,"price":1.07,"value":50001.1,"ownership":{"direct":true},"balance_after":180721,"source":{"system":"sec-edgar","filing":"0001593968-16-001319","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/65770/000159396816001319/primary_01.xml","form_type":"4"}}]}